Clinical significance of cholesterol uptake capacity, a novel assay of high-density lipoprotein function, in coronary artery disease
Project/Area Number |
15K09121
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Multi-year Fund |
Section | 一般 |
Research Field |
Cardiovascular medicine
|
Research Institution | Kobe University |
Principal Investigator |
Tatsuro Ishida 神戸大学, 医学研究科, 特命教授 (00379413)
|
Co-Investigator(Kenkyū-buntansha) |
杜 隆嗣 神戸大学, 医学研究科, 特命准教授 (50379418)
平田 健一 神戸大学, 医学研究科, 教授 (20283880)
|
Co-Investigator(Renkei-kenkyūsha) |
SHINKE TOSHIRO 神戸大学, 医学部附属病院, 准教授 (60379419)
|
Research Collaborator |
SHINOHARA MASAKAZU 神戸大学, 大学院医学研究科, 准教授 (80437483)
|
Project Period (FY) |
2015-04-01 – 2018-03-31
|
Project Status |
Completed (Fiscal Year 2017)
|
Budget Amount *help |
¥4,810,000 (Direct Cost: ¥3,700,000、Indirect Cost: ¥1,110,000)
Fiscal Year 2017: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2016: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2015: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
|
Keywords | 高比重リポ蛋白 / コレステロール逆転送 / 動脈硬化 / 冠動脈疾患 / 脂質異常症 / HDL / エイコサペンタエン酸 / コレステロール / 逆転送 / オメガ3系多価不飽和脂肪酸 / リポタンパク質 / 高比重リポタンパク質 / コレステロール引き抜き / 脂質代謝異常 / 循環器 |
Outline of Final Research Achievements |
We established a new method to evaluate the efficiency of HDL-induced cholesterol efflux from macrophages “cholesterol uptake capacity (CUC)” using apoB-depleted serum, fluorescently labeled cholesterol, and immobilized anti-apolipoprotein A1 antibody. When we measured CUC in patients with coronary artery disease, CUC declined with myeloperoxidase-mediated oxidation of HDL, and correlated inversely with requirement of revascularization. Multivariable analysis adjusted for traditional coronary risk factors including HDL-C showed that only CUC remained significant. Furthermore, CUC was lower in patients with lipidic plaque than that in those without lipidic plaque, and inversely associated with the lipid index in these patients. CUC was also inversely associated with Macrophage grade. CUC is an alternative measure of HDL functionality and may be a substitute for cholesterol efflux capacity and applicable for assessing CVD risk.
|
Report
(4 results)
Research Products
(30 results)
-
[Journal Article] Eicosapentaenoic Acid-Enriched High-Density Lipoproteins Exhibit Anti-Atherogenic Properties2018
Author(s)
6.Tanaka N, Irino Y, Shinohara M, Tsuda S, Mori T, Nagao M, Oshita T, Mori K, Hara T, Toh R, Ishida T, Hirata K
-
Journal Title
Circulation Journal
Volume: 82
Issue: 2
Pages: 596-601
DOI
NAID
ISSN
1346-9843, 1347-4820
Related Report
Peer Reviewed
-
-
-
-
[Journal Article] Cholesterol Uptake Capacity: A New Measure of High-Density Lipoprotein Functionality for Coronary Risk Assessment.2017
Author(s)
Harada A, Toh R, Murakami K, Kiriyama M, Yoshikawa K, Miwa K, Kubo T, Irino Y, Tanaka N, Nishimura K, Ishida T, Hirata K.
-
Journal Title
Journal of Applied Laboratory Medicine.
Volume: in press
Related Report
Peer Reviewed / Acknowledgement Compliant
-
-
-
-
-
-
-
-
-
-
-
[Presentation] Inverse Association Between HDL Cholesterol Uptake Capacity And Coronary Atherosclerotic Burden: OCT-based Observation Study2017
Author(s)
Toshihiko Oshita, Ryuji Toh, Amane Harada, Katsuhiro Murakami, Maria Kiriyama, Keiko Yoshikawa, Keiko Miwa, Kenta Mori, Yasuhiro Irino, Hiromasa Otake, Toshiro Shinke, Tatsuro Ishida, Ken-ichi Hirata
Organizer
第81回 日本循環器学会学術集会
Place of Presentation
金沢
Year and Date
2017-03-17
Related Report
-
-
-
-
-
[Presentation] Cholesterol Uptake Capacity: A New Measure of HDL Functionality for Coronary Risk Stratification2016
Author(s)
Amane Harada, Ryuji Toh, Katsuhiro Murakami, Maria Kiriyama, Keiko Yoshikawa, Keiko Miwa, Takuya Kubo, Yasuhiro Irino, Kenta Mori, Nobuaki Tanaka, Kunihiro Nishimura, Tatsuro Ishida, Ken-ichi Hirata
Organizer
第33回 ISHR日本部会総会
Place of Presentation
東京
Year and Date
2016-12-16
Related Report
Int'l Joint Research
-
-
[Presentation] Cholesterol uptake capacity, a new concept of HDL functionality, for risk stratification in coronary artery disease2016
Author(s)
Toh R, Harada A, Murakami K, Kiriyama M, Yoshikawa K, Miwa K, Irino Y, Mori K, Tanaka N, Nishimura K, Ishida T, Hirata K.
Organizer
68th AACC Annual Scientific Meeting & Clinical Lab Expo
Place of Presentation
Philadelphia, USA
Year and Date
2016-08-02
Related Report
Int'l Joint Research
-
[Presentation] 高比重リポ蛋白 (HDL) の抗炎症効果はリン脂質構成に依存する2016
Author(s)
Tanaka N, Irino Y, Shinohara M, Tsuda S, Nagao M, Mori K, Mori T, Hara T, Toh R, Ishida T, Hirata K.
Organizer
第48回日本動脈硬化学会総会・学術集会
Place of Presentation
東京
Year and Date
2016-07-14
Related Report
-
[Presentation] Cholesterol Uptake Capacity, a New Measure for High-Density Lipoprotein Functionality And Its Association with Incident Cardiovascular Events.2016
Author(s)
Harada A, Toh R, Murakami K, Kiriyama M, Yoshikawa K, Kubo T, Miwa K, Irino Y, Mori K, Tanaka N, Ishida T, Hirata K.
Organizer
第80回日本循環器学会学術集会
Place of Presentation
仙台
Year and Date
2016-03-18
Related Report
-
-
-
[Presentation] Serum Myeloperoxidase/Paraoxonase 1 Ratio Predicts Recurrent Coronary Artery Disease2015
Author(s)
Tsuda S, Toh R, Mori K, Nagao M, Tanaka N, Mori T, Monguchi T, Nakajima H, Honjo T, Shinohara M, Nishimura K, Ishida T, Hirata K
Organizer
第47回 日本動脈硬化学会総会学術集会
Place of Presentation
仙台
Year and Date
2015-07-10
Related Report
-
[Presentation] 冠動脈疾患二次予防における予測因子としての血清ミエロペルオキシダーゼ/パラオキソナーゼ1比の有用性についての検討2015
Author(s)
Tsuda S, Toh R, Mori K, Nagao M, Tanaka N, Mori T, Monguchi T, Nakajima H, Honjo T, Shinohara M, Nishimura K, Ishida T, Hirata K
Organizer
第15回日本NO学会
Place of Presentation
大阪
Year and Date
2015-06-26
Related Report
-
[Presentation] Serum myeloperoxidase/paraoxonase 1 ration predicts recurrent coronary artery disease2015
Author(s)
Tsuda S, Toh R, Mori K, Nagao M, Tanaka N, Mori T, Monguchi T, Nakajima H, Honjo T, Shinohara M, Nishimura K, Ishida T, Hirata K
Organizer
ATVB/PVD2015
Place of Presentation
サンフランシスコ、アメリカ
Year and Date
2015-05-08
Related Report
Int'l Joint Research